Positive scientific opinion from the European Medicines Agency for MSD’s oral antiviral therapy in development against COVID-19 Save Print 24.11.2021 08:00 Europe/Zurich This message is password-protected and is intended exclusively for media representatives. Please enter the password. Media representatives can request the login data here: media.switzerland@msd.com Do you have a question or need more information? Here you will find the right media contact. Password: What can we help you find? Search for:
